Neuropathic pain is a complex, chronic pain caused by damage to the nervous system, affecting 6.9% to 10% of the population globally. In contemporary society, the therapeutic efficacy of high-frequency spinal cord stimulation (HF10) at 10 kHz has been confirmed by multiple studies and clinical tests, especially in alleviating pain associated with complex regional pain syndrome (CRPS), diabetes-related neuropathy and Peripheral nerve damage. HF10 therapy not only significantly reduces pain, but also avoids the paresthesia caused by traditional SCS during the treatment process. According to a SENZA study, 88% of participants reported greater than 50% pain reduction after one year, and HF10 excelled at improving daily activities and quality of life. In addition, HF10 treatment has fewer side effects and good long-term effects and is free of paresthesia, making it significantly cost-effective. These findings highlight the potential of HF10 as an innovative treatment in the management of chronic neuropathic pain, providing new hope for patients.
